Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 1–50 of 1,675 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03187288	Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS	completed	Phase 1	13	University Health Network, TorontoOTHER	1	Sep 29, 2026	clinicaltrials
NCT04429191	JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation	completed	Phase 1	32	Jasper Therapeutics, Inc.INDUSTRY	1	Sep 28, 2026	clinicaltrials